We identified that the Ile684Ser variant within the TYK2 gene, which may act through the ICAM1 gene, is associated with many traits including psoriasis, Crohn’s disease, and infections, and may suggest integrins and their receptors as potential drug targets. The gene discussed is ICAM1; the disease is Crohn disease.